Respiratory News and Research

RSS

Microbiologists find way to use statins to fight Hantavirus

wo Perelman School of Medicine microbiologists may have found a way to use statins, the well-known blockbuster cholesterol-lowering drugs, to fight the hantavirus, a mysterious and lethal microorganism that appeared suddenly in the US southwest over 20 years ago.

12 Feb 2014

Researchers demonstrate new approach to treating muscular dystrophy

Researchers at Washington University School of Medicine in St. Louis have demonstrated a new approach to treating muscular dystrophy. Mice with a form of this muscle-weakening disease showed improved strength and heart function when treated with nanoparticles loaded with rapamycin, an immunosuppressive drug recently found to improve recycling of cellular waste.

12 Feb 2014

Jazz Pharmaceuticals' Versacloz now commercially available in the U.S. for schizophrenia

Jazz Pharmaceuticals plc today announced U.S. commercial availability of Versacloz (clozapine, USP) oral suspension, the first and only oral suspension clozapine for severely ill treatment-resistant schizophrenia patients or those at risk of recurrent suicidal behavior with schizophrenia or schizoaffective disorder.

11 Feb 2014

Walgreens collaborates with NMAC to improve treatment outcomes for African Americans with HIV

In collaboration with the National Minority AIDS Council, Walgreens is furthering its commitment to improve HIV treatment outcomes for African Americans living with HIV by deepening pharmacists' training and expanding access to the pneumococcal vaccination specifically indicated for persons living with HIV as incidents of flu and pneumonia rise.

11 Feb 2014

Ario Pharma begins XEN-0501 Phase IIa study for treatment persistent cough in COPD patients

Ario Pharma Ltd, the Cambridge biopharmaceutical company developing innovative new approaches to treat respiratory disease, announced today that it has commenced a Phase IIa study of its TRPV1 antagonist, XEN-0501, for the treatment and prevention of cough in patients with chronic obstructive pulmonary disease (COPD). Persistent cough in COPD and other respiratory conditions present as a huge unmet medical need, with novel therapies urgently needed to improve the quality of life of patients.

11 Feb 2014

Zoetis reports revenue of $1.25 billion for Q4 2013

Zoetis Inc. today reported its financial results for the fourth quarter and full year 2013. The company reported revenue of $1.25 billion for the fourth quarter of 2013, an increase of 7% from the fourth quarter of 2012. Revenue reflected an operational increase of 9%, with foreign currency having a negative impact of 2 percentage points.

11 Feb 2014

Unvaccinated flu patients need more intensive care

A snapshot of patients who required care at Duke University Hospital during this year's flu season shows that those who had not been vaccinated had severe cases and needed the most intensive treatment.

11 Feb 2014

Researchers promote scientific and health prevention culture among national population

The Mexican enterprise "Science that breathes" is supported by the National Institutes of Respiratory Diseases and Carcinology among others.

11 Feb 2014

Air pollution puts pressure on primary care

Research in Hong Kong shows that air pollution concentrations are significantly associated with the number of consultations for upper respiratory tract infections (URTIs), contributing to the burden on primary care services.

10 Feb 2014

Scientists identify factors that predict flu severity in patients

St. Jude Children's Research Hospital scientists have identified a signature immune response that might help doctors identify which newly diagnosed influenza patients are most likely to develop severe symptoms and suffer poor outcomes. The findings also help explain why infants and toddlers are at elevated risk for flu complications. The research appears in the upcoming issue of the American Journal of Respiratory and Critical Care Medicine.

10 Feb 2014

Finding could lead to first effective vaccine against respiratory syncytial virus

Vanderbilt University scientists have contributed to a major finding, reported today in the journal Nature, which could lead to the first effective vaccine against respiratory syncytial virus (RSV), a significant cause of infant mortality.

9 Feb 2014

Infection contributes to higher risk of stroke death among blacks

Infection is a stronger trigger of stroke death in African- Americans than in whites, a University of Michigan study shows.

9 Feb 2014

Loyola University toxicologist to talk about rise seen in heroin overdoses in recent years

In the wake of actor Philip Seymour Hoffman's death, Loyola University Health System toxicologist Christina Hantsch, MD, FACEP, FACMT, is available to talk about the rise she has seen in heroin overdoses in recent years.

7 Feb 2014

Invacare reports net loss per share of $0.19 in fourth quarter 2013

Invacare Corporation today announced its financial results for the quarter and year ended December 31, 2013.

6 Feb 2014

Children with FSE who receive earlier treatment with AEDs experience reduction in duration of seizure

New research shows that children with febrile status epilepticus (FSE) who receive earlier treatment with antiepileptic drugs (AEDs) experience a reduction in the duration of the seizure.

6 Feb 2014

TSRI scientists design artificial proteins as a candidate vaccine against RSV

Scientists at The Scripps Research Institute (TSRI) have invented a new method for designing artificial proteins, and have used it to make key ingredients for a candidate vaccine against a dangerous virus, respiratory syncytial virus (RSV), a significant cause of infant mortality.

6 Feb 2014

Researchers design new vaccine for human-infecting respiratory syncytial virus

Vaccines are the safest, cheapest and most effective way to protect against infectious diseases. But to make a good one is still a challenge, and traditional approaches are now stretched to the limit while fatal diseases, like HIV and malaria, remain without vaccine.

6 Feb 2014

Overweight, obese adults can breathe 7-50% more air per day than adult with healthy weight

Overweight or obese adults can breathe 7-50% more air per day than an adult with healthy weight does, which makes them more vulnerable to air contaminants causing asthma and other pulmonary diseases, according to a study by Dr. Pierre Brochu, a professor at Université de Montréal's School of Public Health.

5 Feb 2014

Edison's vatiquinone receives Orphan Status for treatment of Friedreich's ataxia

Edison Pharmaceuticals today announced that the US Food and Drug Administration has granted Orphan Status to vatiquinone for the treatment of Friedreich's ataxia.

4 Feb 2014

Study reveals link between neonatal and early childhood outcomes among premature infants

In a study to be presented on Feb. 6 at 3:15 p.m. CST, at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting-, in New Orleans, researchers will report on a correlation between initial neonatal and early childhood outcomes among children delivered less than 34 weeks gestation.

4 Feb 2014

Respiratory News and Research

Microbiologists find way to use statins to fight Hantavirus

Researchers demonstrate new approach to treating muscular dystrophy

Jazz Pharmaceuticals' Versacloz now commercially available in the U.S. for schizophrenia

Walgreens collaborates with NMAC to improve treatment outcomes for African Americans with HIV

Ario Pharma begins XEN-0501 Phase IIa study for treatment persistent cough in COPD patients

Zoetis reports revenue of $1.25 billion for Q4 2013

Unvaccinated flu patients need more intensive care

Researchers promote scientific and health prevention culture among national population

Air pollution puts pressure on primary care

Scientists identify factors that predict flu severity in patients

Finding could lead to first effective vaccine against respiratory syncytial virus

Infection contributes to higher risk of stroke death among blacks

Loyola University toxicologist to talk about rise seen in heroin overdoses in recent years

Invacare reports net loss per share of $0.19 in fourth quarter 2013

Children with FSE who receive earlier treatment with AEDs experience reduction in duration of seizure

TSRI scientists design artificial proteins as a candidate vaccine against RSV

Researchers design new vaccine for human-infecting respiratory syncytial virus

Overweight, obese adults can breathe 7-50% more air per day than adult with healthy weight

Edison's vatiquinone receives Orphan Status for treatment of Friedreich's ataxia

Study reveals link between neonatal and early childhood outcomes among premature infants

How can microdialysis benefit drug development

Global and Local Efforts to Take Action Against Hepatitis

Addressing Important Cardiac Biology Questions with Shotgun Top-Down Proteomics

Latest News